Navigate Biopharma Services Announces A Strategic Collaboration With BD To Explore Opportunities To Develop And Commercialize Flow Cytometry-based Companion Diagnostics And Tools For Clinical Decisions
Portfolio Pulse from Benzinga Newsdesk
Navigate Biopharma Services has announced a strategic collaboration with Becton, Dickinson and Company (BDX) to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.
September 07, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Becton, Dickinson and Company (BDX) has entered into a strategic collaboration with Navigate Biopharma Services to develop and commercialize diagnostic tools. This could potentially lead to new revenue streams for BDX.
The strategic collaboration between BDX and Navigate Biopharma Services to develop and commercialize diagnostic tools could potentially open up new revenue streams for BDX. This is likely to have a positive impact on BDX's stock in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100